Cunningham E, Sloman G
Med J Aust. 1977 Mar 12;1(11):370-2. doi: 10.5694/j.1326-5377.1977.tb130732.x.
Procaineamide is now available as a sustained-release preparation. This preparation was administered in an eight-hourly regime to 26 patients, and therapeutic blood levels were obtained for the duration of the 56-hour study period in 20 patients. No side effects were observed. Inadequate blood levels may be predicted from a single blood level eight hours after the first dose, which could allow for dosage adjustment.
普鲁卡因酰胺现在有缓释制剂。该制剂以每八小时一次的给药方案给予26名患者,在56小时的研究期间,20名患者的血药浓度维持在治疗水平。未观察到副作用。首次给药八小时后的单次血药浓度可预测血药浓度不足,从而可据此调整剂量。